Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$756M |
| 4 |
Tesla
TSLA
|
+$466M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
| 5 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$42.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.22% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Protagonist Therapeutics
PTGX
$9.91B
| $2.4M | ﹤0.01% |
101,500
+7,300
| +8% | +$206K |
|
1927
RadNet
RDNT
$6.02B
| $2.4M | ﹤0.01% |
107,400
+8,500
| +9% | +$208K |
|
1928
Axsome Therapeutics
AXSM
$11.4B
| $2.4M | ﹤0.01% |
58,000
+4,500
| +8% | +$139K |
|
1929
National Beverage
FIZZ
$2.93B
| $2.4M | ﹤0.01% |
55,200
+3,800
| +7% | +$165K |
|
1930
Ichor Holdings
ICHR
$2.71B
| $2.39M | ﹤0.01% |
67,200
+4,800
| +8% | +$187K |
|
1931
Madrigal Pharmaceuticals
MDGL
$12.2B
| $2.38M | ﹤0.01% |
24,300
+2,300
| +10% | +$194K |
|
1932
Huron Consulting
HURN
$2.39B
| $2.38M | ﹤0.01% |
51,900
+2,500
| +5% | +$115K |
|
1933
Blink Charging
BLNK
$86M
| $2.38M | ﹤0.01% |
89,800
+6,600
| +8% | +$155K |
|
1934
Federal Agricultural Mortgage
AGM
$2.53B
| $2.37M | ﹤0.01% |
21,881
+1,600
| +8% | +$196K |
|
|
CHCT
1935
Community Healthcare Trust
CHCT
$438M
| $2.37M | ﹤0.01% |
56,200
+4,500
| +9% | +$195K |
|
|
KYNB
1936
Kyntra Bio
KYNB
$28.7M
| $2.37M | ﹤0.01% |
7,892
+564
| +8% | +$197K |
|
|
SCS
1937
DELISTED
Steelcase
SCS
| $2.37M | ﹤0.01% |
198,500
+9,500
| +5% | +$115K |
|
1938
Bally's
BALY
$670M
| $2.37M | ﹤0.01% |
77,125
+5,300
| +7% | +$179K |
|
|
FRG
1939
DELISTED
Franchise Group, Inc.
FRG
| $2.37M | ﹤0.01% |
57,200
+4,200
| +8% | +$194K |
|
|
TWOU
1940
DELISTED
2U Inc
TWOU
| $2.37M | ﹤0.01% |
5,940
+460
| +8% | +$185K |
|
1941
Cars.com
CARS
$649M
| $2.36M | ﹤0.01% |
163,400
+11,800
| +8% | +$181K |
|
|
XRN
1942
Chiron Real Estate Inc
XRN
$487M
| $2.35M | ﹤0.01% |
28,840
+1,980
| +7% | +$162K |
|
1943
Nektar Therapeutics
NKTR
$2.59B
| $2.35M | ﹤0.01% |
29,093
+2,133
| +8% | +$316K |
|
|
PLYA
1944
DELISTED
Playa Hotels & Resorts
PLYA
| $2.35M | ﹤0.01% |
271,900
+16,700
| +7% | +$138K |
|
1945
Donnelley Financial Solutions
DFIN
$1.17B
| $2.35M | ﹤0.01% |
70,600
+4,000
| +6% | +$143K |
|
1946
Ero Copper
ERO
$3.59B
| $2.34M | ﹤0.01% |
160,100
+14,100
| +10% | +$196K |
|
1947
Parsons
PSN
$4.99B
| $2.34M | ﹤0.01% |
60,500
+4,100
| +7% | +$140K |
|
1948
Buckle
BKE
$2.31B
| $2.34M | ﹤0.01% |
70,700
+4,700
| +7% | +$174K |
|
1949
Payoneer
PAYO
$2.42B
| $2.32M | ﹤0.01% |
521,100
+36,800
| +8% | +$186K |
|
1950
Metropolitan Bank Holding Corp
MCB
$1.17B
| $2.31M | ﹤0.01% |
22,700
+1,600
| +8% | +$166K |
|
Similar funds
Swiss National Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Swiss National Bank held 2,722 positions worth $177B, up 6.8% from $166B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank deployed $20.2B of net new capital in Q1 2022, opening 3 new positions and adding to 2,642 existing holdings. Its largest new stake was Constellation Energy: 1,411,783 shares worth $79.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Exelon, an estimated $41.2M trimmed.
- Swiss National Bank's largest Q1 2022 buy was Constellation Energy: 1,411,783 shares worth $79.4M.
- Swiss National Bank added most to Apple in Q1 2022, an estimated $1.38B increase.
- Swiss National Bank's biggest Q1 2022 reduction was Exelon, cutting an estimated $41.2M.
- Swiss National Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $199M.
- Swiss National Bank's ten largest holdings make up 28% of its $177B portfolio in Q1 2022.
- Swiss National Bank opened 3 new positions and closed 31 in Q1 2022.
- Swiss National Bank's portfolio value rose 6.8% quarter-over-quarter to $177B.
Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.